Annual Total Long Term Liabilities
$630.00 K
-$306.00 K-32.69%
December 1, 2024
Summary
- As of February 26, 2025, VKTX annual total long term liabilities is $630.00 thousand, with the most recent change of -$306.00 thousand (-32.69%) on December 1, 2024.
- During the last 3 years, VKTX annual total long term liabilities has risen by +$630.00 thousand (+100.00%).
- VKTX annual total long term liabilities is now -86.70% below its all-time high of $4.74 million, reached on December 31, 2015.
Performance
VKTX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$630.00 K
-$125.00 K-16.56%
December 1, 2024
Summary
- As of February 26, 2025, VKTX quarterly total long term liabilities is $630.00 thousand, with the most recent change of -$125.00 thousand (-16.56%) on December 1, 2024.
- Over the past year, VKTX quarterly long term liabilities has stayed the same.
- VKTX quarterly long term liabilities is now -87.57% below its all-time high of $5.07 million, reached on March 31, 2016.
Performance
VKTX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
VKTX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.7% | 0.0% |
| 3 y3 years | +100.0% | +100.0% |
| 5 y5 years | +75.0% | +75.0% |
VKTX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.0% | -100.0% | -57.7% | -100.0% |
| 5 y | 5-year | -50.0% | -100.0% | -57.7% | -100.0% |
| alltime | all time | -86.7% | -100.0% | -87.6% | -100.0% |
Viking Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $630.00 K(-32.7%) | $630.00 K(-16.6%) |
| Sep 2024 | - | $755.00 K(-1.4%) |
| Jun 2024 | - | $766.00 K(-10.1%) |
| Mar 2024 | - | $852.00 K(-9.0%) |
| Dec 2023 | $936.00 K(-25.7%) | $936.00 K(-8.1%) |
| Sep 2023 | - | $1.02 M(-7.5%) |
| Jun 2023 | - | $1.10 M(-6.9%) |
| Mar 2023 | - | $1.18 M(-6.3%) |
| Dec 2022 | $1.26 M(>+9900.0%) | $1.26 M(-5.8%) |
| Sep 2022 | - | $1.34 M(-5.4%) |
| Jun 2022 | - | $1.41 M(-5.1%) |
| Mar 2022 | - | $1.49 M(>+9900.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(-100.0%) |
| Dec 2020 | $29.00 K(-91.9%) | $29.00 K(-74.8%) |
| Sep 2020 | - | $115.00 K(-41.9%) |
| Jun 2020 | - | $198.00 K(-29.0%) |
| Mar 2020 | - | $279.00 K(-22.5%) |
| Dec 2019 | $360.00 K | $360.00 K(-17.8%) |
| Sep 2019 | - | $438.00 K(-14.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $513.00 K(-12.8%) |
| Mar 2019 | - | $588.00 K(+4800.0%) |
| Dec 2018 | $12.00 K(>+9900.0%) | $12.00 K(>+9900.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(-100.0%) |
| Jun 2017 | - | $6100.00(-99.9%) |
| Mar 2017 | - | $4.22 M(>+9900.0%) |
| Dec 2016 | $16.30 K(-99.7%) | $16.30 K(-20.5%) |
| Sep 2016 | - | $20.50 K(-16.7%) |
| Jun 2016 | - | $24.60 K(-99.5%) |
| Mar 2016 | - | $5.07 M(+7.0%) |
| Dec 2015 | $4.74 M(+78.5%) | $4.74 M(>+9900.0%) |
| Sep 2015 | - | $19.10 K(>+9900.0%) |
| Jun 2015 | - | $0.00(-100.0%) |
| Mar 2015 | - | $2.90 M(+9.2%) |
| Dec 2014 | $2.65 M(+774.7%) | $2.65 M(+103.6%) |
| Jun 2014 | - | $1.30 M(+308.5%) |
| Mar 2014 | - | $319.10 K |
| Dec 2013 | $303.50 K(+495.1%) | - |
| Dec 2012 | $51.00 K | - |
FAQ
- What is Viking Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Viking Therapeutics?
- What is Viking Therapeutics annual total long term liabilities year-on-year change?
- What is Viking Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Viking Therapeutics?
- What is Viking Therapeutics quarterly long term liabilities year-on-year change?
What is Viking Therapeutics annual total long term liabilities?
The current annual total long term liabilities of VKTX is $630.00 K
What is the all time high annual total long term liabilities for Viking Therapeutics?
Viking Therapeutics all-time high annual total long term liabilities is $4.74 M
What is Viking Therapeutics annual total long term liabilities year-on-year change?
Over the past year, VKTX annual total long term liabilities has changed by -$306.00 K (-32.69%)
What is Viking Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of VKTX is $630.00 K
What is the all time high quarterly long term liabilities for Viking Therapeutics?
Viking Therapeutics all-time high quarterly total long term liabilities is $5.07 M
What is Viking Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, VKTX quarterly total long term liabilities has changed by $0.00 (0.00%)